BCAB NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Bioatla Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 3.29 USD
-2.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -53.3% below the Trend Line and sits at 0.2% of its 52-week range. The latest completed week returned -2.4%, after a -21.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 51/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 25 out of 100
Latest Close 3.29 USD 31 Jul 2026
1W Return -2.4% latest completed week
4W Return -21.5% short-term follow-through
12W Return -32.0% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.4% Latest completed week; four-week move -21.5%. Indicator stack 19/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 51/100 conviction; expected move 18.9%. News sentiment 49/100 48 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -53.3% below the Trend Line and sits at 0.2% of its 52-week range. The latest completed week returned -2.4%, after a -21.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0212-week average 0.01

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -21.5% over four weeks, -32.0% over 12 weeks, and -80.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.4%
4W-21.5%
12W-32.0%
26W-75.5%
52W-80.1%
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.62Latest activity-pressure read.
Pressure change2929.0%Four-week change in activity pressure.
Leadership-84.27Latest relative-leadership reading.
RS change-2.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 73% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value60/100Relative valuation strength. Underlying universe rank 41; rank 1 is best.
Quality58/100Profitability and accounting quality. Underlying universe rank 43; rank 1 is best.
Momentum60/100Medium-term price momentum. Underlying universe rank 41; rank 1 is best.
Growth60/100Revenue and earnings growth. Underlying universe rank 41; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.8x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-236.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-371.0%
Gross profit retained from each unit of revenue.
Operating margin
-2404.9%
Operating profit retained from revenue.
Free-cash-flow margin
-1149.2%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-81.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-9.2%
Net share repurchases relative to market value.
Shareholder yield
-9.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

BCAB shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 18.9%, and Sharemaestro trend signal inactive.

Conviction51/100
Expected move18.9%
Put/call volume0.00
Pressure100
Speculation9
Volatility69
Trend agreement0
Open options detail
Insider activity0 / 3

0 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment49/100

Weighted news tone is neutral across 48 relevant articles.

4 positive · 39 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move18.9%Nearest-chain priced movement where available.
52-week drawdown-95.4%Distance below the 52-week high.
13-week volatility10.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+45.2%Week of 27 Feb.
Worst week-32.2%Week of 6 Mar.
Latest week-2.4%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains4
Flat weeks0
Modest losses2
Sharp losses13
Recent vol10.9%13-week weekly-return volatility.
Base vol17.3%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew12.4% / -14.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis16/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.02; No reversal markers Factors62/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 86 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

BCAB shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 18.9%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 18.9% Sentiment49/100

Weighted news tone is neutral across 48 relevant articles.

BCAB Q2'26 Earnings: revenue estimate is 0 USD Insiders0 / 3

0 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20263.29 USD-2.4%7.05 USD57.25 USD0.62-84.2792.6KOff
24 Jul 20263.37 USD-14.7%7.83 USD58.11 USD0.55-84.06173.9KOff
17 Jul 20263.95 USD3.4%9.11 USD59.02 USD0.38-81.91212.6KOff
10 Jul 20263.82 USD-8.8%10.23 USD59.93 USD0.14-83.49386.4KOff
3 Jul 20264.19 USD13.9%11.48 USD60.77 USD-0.02-81.89214.3KOff
26 Jun 20263.68 USD0.7%12.71 USD61.64 USD-0.24-84.22404.6KOff
19 Jun 20263.65 USD-5.3%14.10 USD62.58 USD-0.26-85.29218.4KOff
12 Jun 20263.86 USD15.9%15.42 USD63.68 USD-0.24-84.35240.2KOff
5 Jun 20263.33 USD-15.3%16.61 USD64.86 USD-0.22-86.44446.6KOff
29 May 20263.93 USD6.5%17.64 USD66.01 USD-0.14-85.05191.4KOff
22 May 20263.69 USD-13.6%18.68 USD67.10 USD-0.23-85.82192.6KOff
15 May 20264.27 USD-11.8%19.82 USD68.07 USD-0.34-83.68107.4KOff
8 May 20264.84 USD13.3%21.06 USD69.11 USD-0.48-81.87193.8KOff
1 May 20264.27 USD-12.3%22.35 USD70.26 USD-0.70-83.44127.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.